Clinical Trial Update: Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for 22q13 Deletion Syndrome (Phelan-McDermid Syndrome) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• 22q13 Deletion Syndrome
• Phelan-mcdermid Syndrome

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: 22q13 Deletion Syndrome, Phelan-McDermid Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2022-05-12